Compare Agilysys Inc (AGYS) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilysys Inc vs Mesoblast Limited — how do they compare? Agilysys Inc trades at $106.05 (market cap $3.00B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Agilysys Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| AGYS | MESO | |
|---|---|---|
Market Cap | $3.00B | $2.21B |
Sector | Technology | Technology |
52-Week High | $141.12 | $20.96 |
52-Week Low | $62.19 | $12.88 |
Enterprise Value | $2.90B | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilysys Inc
Agilysys provides enterprise software and SaaS solutions for the hospitality industry. Its products specialize in point-of-sale, property management, and inventory systems for hotels, resorts, and cruise lines.
Read more on AGYS →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
